Adding Anagliptin to Insulin and Metformin Enhances T2D Care

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.
Medscape Medical News

source https://www.medscape.com/viewarticle/adding-anagliptin-insulin-and-metformin-enhances-t2d-care-2025a1000hkj?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension